Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses.

In this study, we also observed an increasing trend of tumor-infiltrated T cells and NK cells after JCXH-211 administration, although the data showed significant differences only when combined with anti-PD1 antibodies.

also in 63,971 other papers